SELECTIVE JAK2 INHIBITORS AND THEIR USES

AR135548A1Pending Publication Date: 2026-09-30V6 THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ARP20250100772
Authority / Receiving Office
AR · AR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-08
Filing Date
2025-03-25
Publication Date
2026-09-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

This document describes compounds that are JAK2 inhibitors, methods for preparing such compounds, pharmaceutical compositions and medicinal products containing such compounds, and methods for using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of JAK2 activity. A compound of formula (1). A pharmaceutical composition comprising the compound according to any one of claims 1-72, or one of its pharmaceutically acceptable salts, N-oxides, tautomers, or solvates, and a pharmaceutically acceptable excipient.